PP
IBB icon

Paloma Partners’s iShares Biotechnology ETF IBB Stock Holding History

Paloma Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,100
Closed -$806K – 191
2024
Q4 		$806K Sell
6,100
-11,200
-65% -$1.57M 0.04% 169
2024
Q3 		$2.52M Sell
17,300
-1,500
-8% -$217K 0.07% 239
2024
Q2 		$2.58M Buy
+18,800
New +$2.51M 0.07% 293
2024
Q1 		– Sell
-23,600
Closed -$3.21M – 920
2023
Q4 		$3.21M Buy
+23,600
New +$2.88M 0.12% 191
2023
Q3 		– Sell
-9,800
Closed -$1.24M – 803
2023
Q2 		$1.24M Buy
9,800
+4,200
+75% +$546K 0.04% 319
2023
Q1 		$723K Sell
5,600
-52,200
-90% -$6.83M 0.03% 427
2022
Q4 		$7.59M Sell
57,800
-16,000
-22% -$2.07M 0.35% 41
2022
Q3 		$8.63M Buy
+73,800
New +$9.16M 0.39% 28
2019
Q4 		– Sell
-31,500
Closed -$3.13M – 2315
2019
Q3 		$3.13M Sell
31,500
-15,900
-34% -$1.66M 0.07% 259
2019
Q2 		$5.17M Buy
+47,400
New +$5.04M 0.09% 185
2018
Q4 		– Sell
-4,000
Closed -$488K – 1500
2018
Q3 		$488K Buy
+4,000
New +$471K 0.01% 1038
2018
Q1 		– Sell
-135,000
Closed -$14.4M – 2083
2017
Q4 		$14.4M Sell
135,000
-5,100
-4% -$545K 0.19% 78
2017
Q3 		$15.6M Buy
+140,100
New +$15M 0.21% 60
2017
Q2 		– Sell
-227,100
Closed -$22.2M – 2296
2017
Q1 		$22.2M Buy
227,100
+106,500
+88% +$10.2M 0.27% 52
2016
Q4 		$10.7M Buy
120,600
+2,700
+2% +$246K 0.1% 113
2016
Q3 		$11.4M Sell
117,900
-4,200
-3% -$400K 0.14% 92
2016
Q2 		$10.5M Buy
+122,100
New +$11M 0.12% 97
2016
Q1 		– Sell
-24,000
Closed -$2.71M – 1944
2015
Q4 		$2.71M Buy
24,000
+13,800
+135% +$1.5M 0.07% 254
2015
Q3 		$1.03M Buy
+10,200
New +$1.22M 0.02% 635
2015
Q2 		– Sell
-22,500
Closed -$2.58M – 1852
2015
Q1 		$2.58M Buy
+22,500
New +$2.48M 0.07% 234

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Paloma Partners's IBB Position: Q1 2025 in Review

Paloma Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 1,680 shares — an estimated $222K sold.

Paloma Partners first reported a position in IBB in Q1 2014 and held it in 31 quarters. The position peaked at $49.6M in Q2 2017. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Paloma Partners reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Paloma Partners sold 1,680 iShares Biotechnology ETF shares in Q1 2025, an estimated $222K.
  • Paloma Partners first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 31 quarters.
  • Paloma Partners's iShares Biotechnology ETF position peaked at $49.6M in Q2 2017.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Paloma Partners's 13F filing for Q1 2025, filed 15 May 2025.